AAFP: Keep REMS continuing medical education voluntary

08/1/2013 | AAFP News Now

Prescribers should be involved in deciding whether and how risks of certain classes of drugs and biologics will be mitigated in risk evaluation and mitigation strategies, the AAFP's Ann Karty, M.D., told an FDA meeting on the challenges of REMS standardization and assessment. Karty, who presented information on REMS requirements for extended-release and long-acting opioids, said that REMS continuing medical education should remain voluntary for prescribers and that mandating CME could create confusion for physicians and limit patient access to drugs.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health